Martlet Capital

Martlet Capital is a pre-seed and seed stage investor based in Cambridge, providing patient capital to deep technology and life sciences B2B startups with high growth potential. The firm seeks to support entrepreneurs with value beyond capital, offering assistance in scaling companies from initial funding through to exit. Martlet Capital has invested in over 70 startups since its inception in 2011, achieving multiple successful exits through IPOs, secondaries, and acquisitions by global technology companies. In May 2024, EMV Capital acquired Martlet Capital's operational business and was appointed as the investment manager, overseeing a portfolio of approximately £23.3 million across 53 companies in the deep tech and life sciences sectors. This strategic move aims to leverage EMV Capital's active management strategy to maximize returns for Martlet Capital's shareholders and further advance its position within Cambridge's dynamic tech ecosystem. Martlet Capital's investment focus includes sectors such as artificial intelligence, machine learning, digital health, personalized medicine, engineering, internet of things, new materials, quantum technologies, semiconductors, sensing, space technology, sustainable technologies, and wireless communications. The firm typically invests between €100,000 and €1.5 million in pre-seed, seed, Series A, and Series B funding stages, primarily within the United Kingdom. Notable exits from Martlet Capital's portfolio include companies like Abcam, Cambridge CMOS Sensors, Arachnys, and Audio Analytic. The firm's operational VC business is owned and portfolio managed by EMV Capital, a venture capital investor specializing in high-growth deep tech and life sciences companies.